GSM9742086: G, CAR-T-cells, GEX; Homo sapiens; RNA-Seq
Cells were sorted for live, CD3+, and CAR+ cells from 13 patients at early (days 7-14), intermediate (days 25-35), and late (days 60-90 post-infusion) timepoints. Cells were hashed and batched to preserve identity and ensure similar frequencies of cells from both cilta- and ide-cel treated patients. Libaries construction for both scRNA and CITE followed manufacturer protocols (10X genomics).